Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

November 11, 2020 | Comments Off on Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

Annals of Surgical Oncology 2020 October [Link] Akifumi Nakamura, Nobuyuki Kondo, Toru Nakamichi, Masaki Hashimoto, Teruhisa Takuwa, Seiji Matsumoto, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa Abstract Background: A few studies…

Mesothelioma risk among those exposed to chrysotile asbestos only and mixtures that include amphibole: a case-control study in the USA, 1975-1980

November 10, 2020 | Comments Off on Mesothelioma risk among those exposed to chrysotile asbestos only and mixtures that include amphibole: a case-control study in the USA, 1975-1980

Occupational and Environmental Medicine 2020 October 21 [Link] Jason Y Y Wong, Carol Rice, Aaron Blair, Debra T Silverman Abstract Objectives: Occupational asbestos exposure is causally linked to mesothelioma. However,…

The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma

November 9, 2020 | Comments Off on The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma

Radiology and Oncology 2020 October 21 [Link] Petra Piber, Neza Vavpetic, Katja Goricar, Vita Dolzan, Viljem Kovac, Alenka Franko Abstract Background Asbestos exposure is associated with the development of pleural…

CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative

November 6, 2020 | Comments Off on CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative

Annals of Surgical Oncology 2020 October 18 [Link] David Roife, Benjamin D Powers, Mohammad Y Zaidi, Charles A Staley, Jordan M Cloyd, Ahmed Ahmed, Travis Grotz, Jennifer Leiting, Keith Fournier,…

A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma

November 5, 2020 | Comments Off on A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma

EBioMedicine 2020 October 9 [Link] Bill T V Duong, Licun Wu, Brenda J Green, Fatemeh Bavaghar-Zaeimi, Zongjie Wang, Mahmoud Labib, Yuxiao Zhou, Fernando J P Cantu, Thurgaa Jeganathan, Sandra Popescu,…

Effect of asbestos exposure on differentiation and function of cytotoxic T lymphocytes

November 4, 2020 | Comments Off on Effect of asbestos exposure on differentiation and function of cytotoxic T lymphocytes

Environmental Health and Preventative Medicine 2020 October 8 [Link] Naoko Kumagai-Takei, Yasumitsu Nishimura, Megumi Maeda, Hiroaki Hayashi, Hidenori Matsuzaki, Suni Lee, Kei Yoshitome, Tatsuo Ito, Takemi Otsuki Abstract Asbestos exposure…

Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma

November 3, 2020 | Comments Off on Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma

Thoracic Cancer 2020 October 8 [Link] Oscar Arrieta, Francisco Lozano-Ruiz, Monika Blake-Cerda, Rodrigo Catalán, Luis Lara-Mejía, Miguel Ángel Salinas, Federico Maldonado-Magos, José F Corona-Cruz Abstract Background: Treatment of malignant pleural…

Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis

November 2, 2020 | Comments Off on Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis

Oncology Research and Treatment 2020 October 8 [Link] Xiangxin Zhang, Liu Yang, Wei Chen, Ming Kong Abstract Introduction: Malignant pleural mesothelioma (MPM) is closely linked to asbestos exposure and is…

Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma

October 30, 2020 | Comments Off on Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma

Pharmaceuticals 2020 October 2 [Link] Puey-Ling Chia, Sagun Parakh, Ming-Sound Tsao, Nhu-An Pham, Hui K Gan, Diana Cao, Ingrid J G Burvenich, Angela Rigopoulos, Edward B Reilly, Thomas John, Andrew…

The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma

October 29, 2020 | Comments Off on The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma

Cytopathology 2020 October 6 [Link] Ben Davidson, Annika Jøntvedt Bock, Arild Holth, Dag Andre Nymoen Abstract Objective: To analyze the expression and clinical role of the phosphatase PTPN1 (PTP1B) in…

Categories